
dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners
This transaction follows the sale of the Feed Enzymes activities to Novonesis for €1.5 billion in 2025 and marks the final strategic step for dsm-firmenich to become a fully focused consumer company active in nutrition, health, and beauty.
























